Literature DB >> 3789289

Penetrating wounds to the anterior chest. Analysis of thoracotomy and laparotomy.

B C Borlase, R K Metcalf, E E Moore, F D Manart.   

Abstract

This study of the records of 193 consecutive patients admitted for penetrating anterior chest wounds was carried out to specifically define the need for emergent thoracotomy or laparotomy. The mechanism of injury was a stab wound in 119 patients and a gunshot wound in 74 patients. Seventy-three of the patients (38 percent) required either early thoracotomy (21 percent) or laparotomy (17 percent). In the upper chest region, 83 percent of the operations were thoracotomies, whereas in the lower chest region, 81 percent were laparotomies. Pericardial tamponade, chest tube output, and hypovolemic shock comprised 91 percent of the decisive signs for thoracotomy. The predominant reason for laparotomy was diagnostic peritoneal lavage (63 percent of patients). Plain abdominal roentgenograms were helpful to confirm diaphragmatic missile traverse. Our findings support selective operative management of anterior chest wounds as guided by injury mechanism and entrance location.

Entities:  

Mesh:

Year:  1986        PMID: 3789289     DOI: 10.1016/0002-9610(86)90442-3

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Traumatic pericardial tamponade: relearning old lessons.

Authors:  R Crawford; H Kasem; A Bleetmen
Journal:  J Accid Emerg Med       Date:  1997-07

2.  The role of surgeon-performed ultrasound in patients with possible cardiac wounds.

Authors:  G S Rozycki; D V Feliciano; J A Schmidt; J G Cushman; A C Sisley; W Ingram; J D Ansley
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

Review 3.  Controversies in the management of asymptomatic patients sustaining penetrating thoracoabdominal wounds.

Authors:  Jose Gustavo Parreira; Samir Rasslan; Edivaldo M Utiyama
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.